Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, today announced that it is proceeding with a transition of the CFO functions and appoints Simon Belval as Interim Chief Financial Officer, effective immediately.
Simon Belval is a seasoned professional that has demonstrated strong abilities and leadership in finance and accounting functions including IFRS reporting, tax planning, financing, and risk management in different environments. He has held several leadership roles in the technology and fintech sectors and has developed over the years an expertise in managing strategic initiatives and special situations. He started his career as an external auditor and later acted as senior financial analyst for major organizations in Eastern Canada. Simon is a member of the Ordre des comptables professionnels agrées du Québec (CPA) and a Chartered Financial Analyst (CFA).
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.
For Further Information Please Contact:
Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
News Provided by GlobeNewswire via QuoteMedia
The need for healthcare workers will always exist. However, the challenge for healthcare facilities today is finding reliable, permanent employees. The pandemic only highlighted how extreme the need for flexible, temporary healthcare staffing is, as the global healthcare staffing market reached US$33.8 billion in 2020 — and it’s not slowing down. Experts estimate the global healthcare staffing industry will reach US$47.8 billion by 2026, growing at a compound annual growth rate (CAGR) of six percent. Informed by the pandemic, even as it winds down, healthcare facilities now understand why they need to have access to temporary, on-demand staffing to fill in their gaps.
Despite these very real challenges, the healthcare industry remains notoriously slow to adopt emerging technologies that can improve efficiency and flexibility. Many hospitals depend on staffing agencies that handle all of their processes manually, from onboarding new nurses to placements. However, staffing agencies can only do so much when relying on calls and emails for every process. Even as the healthcare workforce in Canada grows by up to 8 percent per year, too many hospitals rely on outdated methods of finding temporary workers to help cover shifts. Healthcare facilities need a better way to find workers to cover a shift or help out for a few months.
Technology is at the core of Premier Health of America’s platform. The company describes itself as the ‘Uber of healthcare staffing.’ Essentially, the company is a digital disruptor of an industry that struggles to step into the modern world. Premier Health of America created a platform that gives nurses control over where and when they work, while providing facilities with access to a massive workforce to cover any hiring needs.
The company’s mobile app technology, PSweb, is at the core of its operations, and the app has been live for over a decade. Artificial intelligence (AI) and big data power the app, delivering a genuinely automated process to healthcare facilities and professionals. The company maintains support staff that’s available by telephone for anything that may require a human conversation.
Premier Health of America has multiple business units that cater to specific needs. For example, Code Bleu and Premier Health Soin provide qualified healthcare professionals on demand. Meanwhile, Nordik Premier Health is focused on providing healthcare services to remote communities. Segmenting into focused business units allows the company to provide targeted services for healthcare facilities.
While the company currently operates in Canada, its platform is scalable as an international platform, with vast potential in other countries. For example, Premier Health of America plans to service the United States in the future, which it estimates has a market size 12 times larger than its Canadian counterpart.
A team of experienced managers is leading the company towards its ambitious goals. Martin Legault, CEO, has over 25 years of experience in corporate management in companies with over 500 employees. Sylvain Charbonneau, CFO, brings 25 years of financial experience to the company and has served as a board member of three major manufacturing enterprises. Jean-Robert Pronovost has decades of experience in venture capital and strategic divestitures and leads the company's financial development.
PSweb is at the company's core and enables automated staffing solutions disrupting the healthcare staffing industry. The platform has been live for a decade and is undergoing constant development to integrate the latest technology, such as leveraging AI, big data, and machine learning to provide predictive analysis for healthcare facilities.
Premier health recently acquired Umana, a subsidiary of the Canadian Health Care Agency. As a primary provider of nursing services to remote and semi-remote Indfigenous communities in Ontario and Alberta, this provides Premier Health with the opportunity for expansion outside of Quebec.
“The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada’s northern regions,” said Martin Legault, CEO of Premier Health.
Martin Legault is the founder of Premier Soin and has been its chief executive officer since its incorporation in 2003. He has over 25 years of experience in the management and operations of several companies in Québec. Legault’s past experiences include direct responsibility for over 500 employees in the context of international franchises and points of service. Legault holds the title of administrateur agréé, delivered by the Ordre des administrateurs agréés du Québec.
Sylvian Charbonneau joined Premier Health of America in October 2020, bringing over 25 years of management finance experience. Since 2016, he has held a CFO position for Transtex, a C$35 million revenue manufacturing company. In the last 10 years, he acted as chief financial officer and board member for three leading manufacturers, supporting their growth and international expansion. Charbonneau’s career includes experiences working at Deloitte and SGF, formerly Investissement Québec. His strength lies in his leadership, strategic vision, judgment, and the analytical capacity in evaluating investment projects. After earning a bachelor’s of business administration degree, Charbonneau obtained a master’s of business administration from HEC Montreal school of business in 1993.
Jean-Robert Pronovost is a managing partner and co-founder of Cape Partners, a Canadian boutique private equity firm. Before co-founding Cape Partners, Pronovost was a partner and co-founder of IUGO Capital, a family office venture capital fund with investments in Canada, the United States, and Europe. He was responsible for direct investments, strategic divestitures, and restructurings, serving as a board member of several portfolio companies. Previously, Pronovost spent four years at Credit Suisse First Boston, advising on large mergers and acquisitions and executing public and private financings for Canadian and foreign corporate clients. Pronovost also worked for six years in various positions at the Caisse de Dépôt et Placement du Québec, where he elaborated investment allocation strategies and securitization vehicles for alternative assets. He began his career at British Telecom, working as a financial analyst. Pronovost has a degree in economics and finance from Laval University and a joint master’s of business administration from the École Supérieure de Gestion at UQAM and Florida International University.
Giovanni Garay is a seasoned professional that has demonstrated strong abilities in delivering industry-leading service standards, and measurable performance improvements, in fast paced environments. He has held several leadership roles with Scotia Bank, Cap Gemini, and ADP, and has developed over the years an expertise in managing strategic initiatives, including quality framework, training, and coaching programs, as well as client relationship management. Garay is a strong change agent and uses coaching and mentoring to transform teams into high performers, positively impacting organizational culture and effectiveness, and associate development which results in meeting and exceeding corporate objectives. Garay is a natural leader and persuasive communicator with the ability to forge strong relationships across levels and functions.
Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its third quarter ended June 30, 2022.
"We perceive divergences in provincial healthcare policies and management strategies and see geographical diversification as an important element of stability and organic growth," said Martin Legault, CEO of Premier Health. "We believe our recent investments in management and technology infrastructures will facilitate integration and leverage operations in other provinces."
During the third quarter our Premier Soin business unit's revenue remained stable while Code Bleu's business unit revenues decreased by 5.7%. The decrease in revenue at Code Bleu was mainly due to a temporary shift in the business mix during the quarter as well as absenteeism, a situation previously experienced by Premier Soin in the second quarter. Medical personnel are in recuperation mode and we expect a soft summer in terms of hours billed. This exodus of burnt-out health care workers has led to a surge in temporary closure of emergency rooms in Quebec and Ontario. Realisation of this situation by health care authorities and decision makers in Quebec has led to the government dropping some of the restrictions imposed by the ministerial orders in 7 regions of Quebec, and special measures in Ontario as well. Mandatory overtime is also targeted by nurse associations and unions as a major cause of frustration for the healthcare personnel. Taking all this into consideration, we expect an eventual stabilization in hours billed in urban centers, but little headway will be achieved before the fall provincial elections. Our northern regions business units performed in line with our expectations. Since the start of the fiscal year Premier Health Nordik signed contractual arrangements with eleven hospitals, mainly in Northern Ontario and we anticipate a positive impact of these contracts on the revenues before year-end.
Acquisition of Canadian Health Care Agency
We completed our first important acquisition outside of the province of Quebec on April 19. Canadian Health Care Agency is based in Cambridge, Ontario, and provides services in Northern Ontario, Nunavut and Northern Manitoba. The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada's northern regions. CHCA currently has over 200 active and specially trained Registered Nurses and Nurse Practitioners in its organization. The Cambridge based agency provides us with a good management infrastructure in Ontario that will serve as a base to continue our expansion in this province. This is a strategy we are expecting to follow in other provinces as well. We anticipate over 25% of our revenues to be generated outside of Quebec going forward.
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.
Adjusted EBITDA is a non-IFRS financial measure and is defined as net earnings (loss) before finance costs, income tax expense or benefit, and depreciation and amortization, adjusted for share-based compensation, changes in fair value of share warrant obligations, foreign exchange (gain) loss and other non-recurring expenses.
For Further Information Please Contact:
Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
News Provided by GlobeNewswire via QuoteMedia
Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022.
"We invested in our capacity to manage a wider geographical footprint" Said Martin Legault, CEO of Premier Health. "We believe these investments made upstream of contemplated acquisitions will facilitate integration and leverage operations in other provinces."
(1) Adjusted EBITDA before non-recurring items
During the second quarter, our Premier Soin business unit experienced a revenue contraction of 8% while Code Bleu's business unit revenue remained stable. The two subsidiaries offer similar services across the province of Quebec with different pricing strategy and resource profiles that sometimes lead to positive or negative revenue generation discrepancies. The decrease in revenue at Premier Soin was mainly caused by a lower demand for longer term replacement periods and a higher demand for short-term daily shifts. This business mix often results in a higher turnover rate and, by extension, a higher risk of not being able to fulfill every request for resources on short notice due to personnel availability. We believe this temporary impact is related to an adjustment period in the receding pandemic. We already experienced a shift from this situation in April but still expect a certain level of volatility in the near future. The Nordik business unit continued its organic growth steadily during the quarter with an increased deployment of resources in Northern Ontario, Northern Quebec, and James Bay. During the quarter, Premier Soin Nordik signed contractual arrangements with 6 additional hospitals. This follows the five contracts that were signed earlier in the first quarter in Northern Ontario.
The Corporation is still experimenting supply chain issues, which resulted in new vehicle deliveries being further postponed. The first 3 new transport units which delivery was postponed to March 2022 are now scheduled to be delivered only at the end of the third quarter. This resulted in higher-than-expected maintenance costs that are impacting EBTDA margins and net income.
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.
Earnings before interest, taxes, depreciation and amortization ("EBITDA"), is calculated as the net profit (loss), before non-recurring items excluding acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation), interest expense, net of interest income and income tax expense.
For Further Information Please Contact:
Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
News Provided by GlobeNewswire via QuoteMedia
Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announces the appointment of Giovanni Garay as Ontario General Manager, effective immediately.
"We are very excited to have Giovanni join Premier Health. His hiring follows our recent acquisition in Ontario, and he will be an important member of the Corporation's senior leadership team," said Martin Legault, Chief Executive Officer. "Giovanni's experience with large organisations will benefit Premier Health as we continue to expand our footprint in the province." he added.
Giovanni is a seasoned professional that has demonstrated strong abilities in delivering industry-leading service standards and measurable performance improvements in fast paced environments. He has held several leadership roles with Scotia Bank, Cap Gemini, and ADP and has developed over the years an expertise in managing strategic initiatives including quality framework, training, and coaching programs, as well as client relationship management. Giovanni is a strong change agent and uses coaching and mentoring to transform teams into high performers, positively impacting organizational culture and effectiveness, and associate development with results in meeting and exceeding corporate objectives. Giovanni is a Natural leader and persuasive communicator with the ability to forge strong relationships across levels and functions.
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.
For Further Information Please Contact:
Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
News Provided by GlobeNewswire via QuoteMedia
Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation ") announces the grant of 1,090,000 stock options to certain officers and employees of the Corporation. These stock options are granted in accordance with the terms of the stock option plan of the Corporation. All options fully vest on September 30, 2022, and each option entitles the holder thereof to purchase one (1) common share of the Corporation at a price of $0.80 per common share for a period of five (5) years from April 11, 2021. The Corporation also announces that it has granted an aggregate of 664,000 deferred share units (" DSUs ") to six directors of the Corporation. The DSUs are payable in common shares of the Corporation upon the holder ceasing to be a director of the Corporation.
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb software platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.
For Further Information Please Contact :
Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
News Provided by GlobeNewswire via QuoteMedia
Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation "), a leading Canadian Healthtech company, is pleased to announce that it has completed the acquisition of 100% of the outstanding shares of Umana Holdings Inc. (" Umana ") and its wholly-owned subsidiary Canadian Health Care Agency (" CHCA "), through a newly created wholly owned federally incorporated subsidiary, 13822214 Canada (" CanCo "), for a total consideration comprised between C$10.5M to C$14.5M (the " Purchase Price "), payable in cash, depending on the achievement of performance objectives (the " Transaction "), minus indebtedness, as more fully detailed below. As a result of the Transaction and a corporate reorganization, CHCA became a wholly owned subsidiary of the Corporation. The Corporation will continue the business of CHCA which consists in providing specialized nursing services.
"The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada's northern regions" Said Martin Legault, CEO of Premier Health. " In addition, the Cambridge based agency provides us with a good management infrastructure in Ontario that will serve as a base to continue our expansion in this province. This is a strategy we are expecting to follow in other provinces as well."
CHCA is the primary provider to Indigenous Services Canada ("ISC") for nursing services to remote and semi-remote Indigenous communities in both Ontario and Alberta. In addition, CHCA provides nurses services as a backup provider to ISC for these communities in Manitoba. CHCA is based in Cambridge, Ontario, and was founded in 2001 in response to severe staffing shortages in Canada's northern regions. CHCA started its operations in Northern Ontario and quickly expanded its activities to providing services in Nunavut and Northern Manitoba. CHCA currently has over 200 active and specially trained Registered Nurses and Nurse Practitioners in its organization. For the fiscal year ending January 31, 2022, CHCA generated revenues of C$34.5M (of which an estimated C$10.3M were Covid related non-recurring isolation revenues), an EBITDA of C$6.4M (of which an estimated C$3.0M was Covid related non-recurring isolation EBITDA) and a net income of C$4.6M (of which an estimated C$3.0M was Covid related non-recurring isolation net income).
"Our objective is to continue building on our foundation of offering superior care and services to our communities" Said Sharon Umana, CEO of CHCA "Teaming up with Premier Health is a natural fit for us that will allow us to capitalize on the strengths of our nurses and nurse practitioners into even more opportunities to provide care."
CanCo entered into the SPA with the shareholders of Umana on April 7 to acquire all of the issued and outstanding shares of CHCA on a cash and debt free basis for a total cash consideration of up to C$14.5M million, comprised of:
The Transaction is subject to final working capital adjustments to be completed within 90 days following the closing of the Transaction. Acumen Capital Partners acted as adviser for the Transaction.
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb software platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.
Earnings before interest, taxes, depreciation, and amortization (" EBITDA "), is calculated as the net profit (loss), before acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation and stock-based compensation), interest expense, net of interest income and income tax expense.
For Further Information Please Contact :
Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
News Provided by GlobeNewswire via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that it's wholly owned subsidiary, Naturevan Nutrition Ltd. ("Naturevan"), will be distributed through Amazon starting October 1, 2022. The Company has entered into a partnership agreement with an Amazon supply agent, PTPT Stores Corp. ("PTPT") on September 12, 2022, for the distribution of the products to Amazon.
The Company is scheduled to deploy the first shipment through Amazon U.S.A on or about October 1, 2022, followed by Amazon Canada shortly after. Among twenty-two (22) of the Naturevan products, a few products have been chosen for the first roll out, including Probiotics for women, a top-selling supplement on the current Amazon market. Other supplements the Company is reviewing to distribute, which is subject to change, includes Aquamarine Collagen, rTG Omega3 and Cissus plus supplements.
Latest market research shows that Amazon generates approximately $283,000 worth of sales every minute and 89 percent of buyers are more likely to buy products from Amazon over other retailers. Furthermore, the sales of dietary supplements experienced a 54 percent increase with year-over-year growth on Amazon, with probiotics being the most popular dietary supplement sold. (Source: https://www.nutrasciencelabs.com/blog/quick-tips-to-get-approved-to-sell-dietary-supplements-on-amazon)
Additionally, the nutritional supplements market is reported to make $620.8 billion by 2030 according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.3% from 2022 to 2030. With health and fitness on an upscale trend, the Company expects to see great profitable return from the health and wellness market. (Source: https://www.benzinga.com/pressreleases/22/09/n28828852/nutritional-supplements-market-to-hit-620-8-billion-by-2030-grand-view-research-inc)
"With Amazon being one of the most prominent e-commerce platforms for distribution and sale of products, the Company is thrilled to start distributing Naturevan supplements through Amazon North America. With vitamin and supplement products showing strong sales forecasts, we are confident that the first roll out of products will exceed our expectations", said Andrew Ryu, Interim Chief Executive Officer and Chairman of the Company.
Naturevan is a provider of natural health supplements and products that are proudly made in Canada and distributed online and through agents across Canada. Canada's natural health supplement market is globally recognized as having first-rate standards and guidelines, so consumers are getting the highest standard of nutrition. To learn more about Naturevan and its products, visit www.naturevan.ca.
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro's subsidiary, Concierge Medical, is a group of board-certified physicians who provide private, discreet, and personalized healthcare to Canadians. ScreenPro prides itself in having its own medical doctors and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs. ScreenPro also newly introduced Naturevan Nutrition Ltd., to its portfolio, providing vitamins and supplements that are proudly made in Canada and distributed for sale online.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Priya Monique Atwal, Director of Communications Tel: (416) 901-5611 x 204 Email: priya@screenprosecurity.com
Andrew Ryu, Interim Chief Executive Officer and Chairman Tel: 416-901-5611 x 201 Email: aryu@datametrex.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/137166
News Provided by Newsfile via QuoteMedia
About Lake Resources NL: Lake Resources NL (ASX:LKE) (OTCMKTS:LLKKF) is a clean lithium developer utilising clean, direct extraction technology for the development of sustainable, high purity lithium from its flagship Kachi Project, as well as three other lithium brine projects in Argentina. The projects are in a prime location within the Lithium Triangle, where 40% of the world's lithium is produced at the lowest cost. This method will enable Lake Resources to be an efficient, responsibly-sourced, environmentally friendly and cost competitive supplier of high-purity lithium, which is readily scalable, and in demand from Tier 1 electric vehicle makers and battery makers.
Contact: For media queries, please contact: Nigel Kassulke at Teneo M: +61-407-904-874 E: Nigel.Kassulke@teneo.com
News Provided by ABN Newswire via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that its wholly owned subsidiary, Concierge Medical Consultants Inc. ("Concierge"), has introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver.
The Company has launched this new service with six (6) variations of Vitamindrip® products:
1)Hydration - A combination of IV hydration and vitamin additives to immediately eliminate dehydration in the body. 2)Recovery - This type of IV reduces cold and flu symptoms by booting the immune system. 3)Energy - Promotes adrenal function, mental alertness, and stress tolerance. 4)Cosmetic - Enriched with amino acids and active ingredients to repair and stimulate collagen growth naturally within your body. 5)Diet and Detox - Instantly detoxifies your body and boosts your energy with healthy vitamins to flush out unhealth toxins. 6)Immune Boost - Boost the body's immune system with vitamins, minerals, and amino acids.
Vitamindrip® products are used in hospitals and by healthcare professionals worldwide. Vitamindrip® is a scientifically formulated intravenous solution for effective treatment of moderate to severe dehydration, and has been found to be effective against asthma, migraines, fatigue, acute muscle spasm, upper respiratory tract infections, chronic sinusitis, seasonal allergic rhinitis, and other disorders. (Source: https://www.vitamindrip.com/science)
Infused with electrolytes and vitamins, IV Therapy provides immediate hydration into the bloodstream. Patients will experience a boost in energy levels and instantly feel replenished. IV Therapy removes toxins from the body and is an effective treatment to put nutrients back into the body, optimizing patient's overall health. (Source: https://www.vitamindrip.com/science)
"IV Therapy has seen tremendous demand and growth in the market. It also continues to be trending in popularity in the health and wellness industry. From boosting the immune system to helping patients achieve their best health with fast recovery, we are very excited to add this new service", said Andrew Ryu, interim CEO and Chairman of the Company.
To learn more about Concierge Medical's IV Therapy, visit: https://www.conciergemedical.ca/ivvitamintherapy.
To book an IV Vitamin Therapy Service, please visit: https://conciergemedicalca.janeapp.com/#staff_member/9.
For additional information and inquiries on Concierge Medical services please contact info@conciergemedical.ca
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro's subsidiary, Concierge Medical, is a group of board-certified physicians who provide private, discreet, and personalized healthcare to Canadians. ScreenPro prides itself in having its own medical doctors and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs. ScreenPro also newly introduced Naturevan Nutrition Ltd., to its portfolio, providing vitamins and supplements that are proudly made in Canada and distributed for sale online.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Priya Monique Atwal, Director of Communications Tel: (416) 901-5611 x 204 Email: priya@screenprosecurity.com
Andrew Ryu, Interim Chief Executive Officer and Chairman Tel: 416-901-5611 x 201 Email: aryu@datametrex.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/136955
News Provided by Newsfile via QuoteMedia
~Monfort to pay the cash dividend payment to shareholders of Series A Preferred Shares of record on September 23rd ~
Montfort Capital Corporation ("Montfort" or the "Company") (TSXV: MONT) (OTCQB: MONTF), a leading innovator of technology in private credit, today announced that the Company's board of directors has declared a quarterly cash dividend of $0.02 per Series A Preferred Shares ("Preferred Shares"), payable on September 29, 2022 to Series A preferred shareholders of record as at September 23, 2022 . The Corporation's dividend payments qualify as an 'eligible dividend' for Canadian income tax purposes.
Holders of Preferred Shares are entitled to receive fixed non-cumulative preferential cash dividends, if, as and when declared by the board of Directors of the Corporation at an annual rate equal to $0.08 per Preferred Share. Dividends, if declared, will be payable on the last day of December, March, June and September in each year, or if such day is not a business day, on the next business day, at a quarterly rate of $0.02 per Preferred Share.
About Montfort Capital Corporation Montfort manages a diversified family of specialized private credit brands that utilize focused strategies and experienced management teams combined with advanced technology to improve fee related performance. Montfort facilitates transparency for all of its investors through public company reporting. For further information, please visit www.montfortcapital.com .
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Certain information and statements in this news release contain and constitute forward-looking information or forward-looking statements as defined under applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements normally contain words like 'believe', 'expect', 'anticipate', 'plan', 'intend', 'continue', 'estimate', 'may', 'will', 'should', 'ongoing' and similar expressions, and within this news release include any statements (express or implied) respecting the future growth of the Company, the Company's future financial performance and the completion of the Company's previously announced acquisitions,the belief that the Company's business will get stronger in a rising rate environment, and the future declaration of dividends.
Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions and other factors that management currently believes are relevant, reasonable and appropriate in the circumstances, including, without limitation, the following assumptions: that the Company and its investee companies are able to meet their respective future objectives and priorities, assumptions concerning general economic growth and the absence of unforeseen changes in the legislative and regulatory framework for the Company; assumptions regarding the Company's ability to complete its previously announced acquisition on terms favourable to the Company.
Although management believes that the forward-looking statements are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to Montfort's business. Material risks and uncertainties applicable to the forward-looking statements set out herein include, but are not limited to, the Company having insufficient financial resources to achieve its objectives; availability of further investments that are appropriate for the Company on terms that it finds acceptable or at all; successful completion of exits from investments on terms that constitute a gain when no such exits are currently anticipated; intense competition in all aspects of business; reliance on limited management resources; general economic risks; new laws and regulations and risk of litigation. Although Montfort has attempted to identify factors that may cause actual actions, events or results to differ materially from those disclosed in the forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, predicted, estimated or intended. Also, many of the factors are beyond the control of Montfort . Accordingly, readers should not place undue reliance on forward-looking statements. Montfort undertakes no obligation to reissue or update any forward-looking statements as a result of new information or events after the date hereof except as may be required by law. All forward-looking statements contained in this news release are qualified by this cautionary statement.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2022/08/c5656.html
News Provided by Canada Newswire via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that the Company has appointed Mr. Andrew Ryu as the new interim Chief Executive Officer and Chairman effective September 8, 2022.
Lena Kozovski, former Chief Executive Officer, has stepped down from her duties as CEO and Director, but will remain with the Company until the end of the year to help with operations. The former Chairman, Michael Yeung, also stepped down from the board, effective today.
The Company would like to welcome back Mr. Ryu as he has greatly contributed and played a core role in the Company's success in the past. He previously served as interim CEO and Chairman of the Company. Mr. Ryu holds over 20 years of operational experience and is a highly seasoned M&A entrepreneur in public and private companies. He was also nominated as EY Entrepreneur of the Year in 2014. The Company would like to thank Mr. Ryu for accepting this role upon request by the Company and providing his expertise to help advance the Company during this pivotal phase.
Management would like to thank both Ms. Kozovski and Mr. Yeung for their past contribution towards the Company and wish them success in their future endeavours.
"It is with great pleasure that I take on the position as CEO of the Company and take the leadership role in operations to help contribute to the Company's success and its value. I believe my wealth of operational and entrepreneurial experience will take the Company to new heights and elevate ScreenPro to reach its highest potential," said Andrew Ryu, interim CEO and Chairman of the Company.
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro's subsidiary, Concierge Medical, is a group of board-certified physicians who provide private, discreet, and personalized healthcare to Canadians. ScreenPro prides itself in having its own medical doctors and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs. ScreenPro also newly introduced Naturevan Nutrition Ltd., to its portfolio, providing vitamins and supplements that are proudly made in Canada and distributed for sale online.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Priya Monique Atwal, Director of Communications Tel: (416) 901-5611 x 204 Email: priya@screenprosecurity.com
Andrew Ryu, Interim Chief Executive Officer, and Chairman Tel: 416-901-5611 x 201 Email: aryu@datametrex.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/136293
News Provided by Newsfile via QuoteMedia
About Lake Resources NL: Lake Resources NL (ASX:LKE) (OTCMKTS:LLKKF) is a clean lithium developer utilising clean, direct extraction technology for the development of sustainable, high purity lithium from its flagship Kachi Project, as well as three other lithium brine projects in Argentina. The projects are in a prime location within the Lithium Triangle, where 40% of the world's lithium is produced at the lowest cost. This method will enable Lake Resources to be an efficient, responsibly-sourced, environmentally friendly and cost competitive supplier of high-purity lithium, which is readily scalable, and in demand from Tier 1 electric vehicle makers and battery makers.
Contact: For media queries, please contact: Nigel Kassulke at Teneo M: +61-407-904-874 E: Nigel.Kassulke@teneo.com
News Provided by ABN Newswire via QuoteMedia
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.